Literature DB >> 22905295

Implantable cardioverter defibrillator lead-related methicillin resistant Staphylococcus aureus endocarditis: Importance of heightened awareness.

Obiora F Anusionwu1, Cheri Smith, Alan Cheng.   

Abstract

Methicillin resistant Staphylococcus aureus (MRSA) septicemia is associated with high morbidity and mortality especially in patients with immunosuppression, diabetes, renal disease and endocarditis. There has been an increase in implantation of cardiac implantable electronic devices (CIED) with more cases of device-lead associated endocarditis been seen. A high index of suspicion is required to ensure patient outcomes are optimized. The excimer laser has been very efficient in helping to ensure successful lead extractions in patients with CIED infections. We present an unusual case report and literature review of MRSA septicemia from device-lead endocarditis and the importance of early recognition and prompt treatment.

Entities:  

Keywords:  Endocarditis; Implantable cardioverter-defibrillator; Methicillin resistant Staphylococcus aureus; Pacemakers; Sepsis

Year:  2012        PMID: 22905295      PMCID: PMC3421136          DOI: 10.4330/wjc.v4.i7.231

Source DB:  PubMed          Journal:  World J Cardiol


  17 in total

1.  Update on echocardiography in the management of infective endocarditis.

Authors:  John Francis Sedgwick; Darryl John Burstow
Journal:  Curr Infect Dis Rep       Date:  2012-08       Impact factor: 3.725

2.  Transvenous lead extraction: Heart Rhythm Society expert consensus on facilities, training, indications, and patient management: this document was endorsed by the American Heart Association (AHA).

Authors:  Bruce L Wilkoff; Charles J Love; Charles L Byrd; Maria Grazia Bongiorni; Roger G Carrillo; George H Crossley; Laurence M Epstein; Richard A Friedman; Charles E H Kennergren; Przemyslaw Mitkowski; Raymond H M Schaerf; Oussama M Wazni
Journal:  Heart Rhythm       Date:  2009-05-22       Impact factor: 6.343

3.  Mortality and cost associated with cardiovascular implantable electronic device infections.

Authors:  Muhammad R Sohail; Charles A Henrikson; Mary Jo Braid-Forbes; Kevin F Forbes; Daniel J Lerner
Journal:  Arch Intern Med       Date:  2011-09-12

4.  Risk factors associated with early- versus late-onset implantable cardioverter-defibrillator infections.

Authors:  Muhammad R Sohail; Salwa Hussain; Katherine Y Le; Chadi Dib; Christine M Lohse; Paul A Friedman; David L Hayes; Daniel Z Uslan; Walter R Wilson; James M Steckelberg; Larry M Baddour
Journal:  J Interv Card Electrophysiol       Date:  2011-03-02       Impact factor: 1.900

5.  Infective endocarditis: Updated guidelines.

Authors:  U Allen
Journal:  Can J Infect Dis Med Microbiol       Date:  2010       Impact factor: 2.471

6.  Timing of the most recent device procedure influences the clinical outcome of lead-associated endocarditis results of the MEDIC (Multicenter Electrophysiologic Device Infection Cohort).

Authors:  Arnold J Greenspon; Jordan M Prutkin; Muhammad R Sohail; Holenarasipur R Vikram; Larry M Baddour; Stephan B Danik; James Peacock; Carlos Falces; Jose M Miro; Elisabeth Blank; Christoph Naber; Roger G Carrillo; Chi-Hong Tseng; Daniel Z Uslan
Journal:  J Am Coll Cardiol       Date:  2012-02-14       Impact factor: 24.094

7.  Infective endocarditis complicating permanent pacemaker and implantable cardioverter-defibrillator infection.

Authors:  Muhammad R Sohail; Daniel Z Uslan; Akbar H Khan; Paul A Friedman; David L Hayes; Walter R Wilson; James M Steckelberg; Sarah M Jenkins; Larry M Baddour
Journal:  Mayo Clin Proc       Date:  2008-01       Impact factor: 7.616

8.  Prevention of infective endocarditis: guidelines from the American Heart Association: a guideline from the American Heart Association Rheumatic Fever, Endocarditis, and Kawasaki Disease Committee, Council on Cardiovascular Disease in the Young, and the Council on Clinical Cardiology, Council on Cardiovascular Surgery and Anesthesia, and the Quality of Care and Outcomes Research Interdisciplinary Working Group.

Authors:  Walter Wilson; Kathryn A Taubert; Michael Gewitz; Peter B Lockhart; Larry M Baddour; Matthew Levison; Ann Bolger; Christopher H Cabell; Masato Takahashi; Robert S Baltimore; Jane W Newburger; Brian L Strom; Lloyd Y Tani; Michael Gerber; Robert O Bonow; Thomas Pallasch; Stanford T Shulman; Anne H Rowley; Jane C Burns; Patricia Ferrieri; Timothy Gardner; David Goff; David T Durack
Journal:  Circulation       Date:  2007-04-19       Impact factor: 29.690

9.  Update on cardiovascular implantable electronic device infections and their management: a scientific statement from the American Heart Association.

Authors:  Larry M Baddour; Andrew E Epstein; Christopher C Erickson; Bradley P Knight; Matthew E Levison; Peter B Lockhart; Frederick A Masoudi; Eric J Okum; Walter R Wilson; Lee B Beerman; Ann F Bolger; N A Mark Estes; Michael Gewitz; Jane W Newburger; Eleanor B Schron; Kathryn A Taubert
Journal:  Circulation       Date:  2010-01-04       Impact factor: 29.690

10.  Cardiovascular implantable electronic device infection in patients with Staphylococcus aureus bacteremia.

Authors:  Daniel Z Uslan; Taylor F Dowsley; Muhammad R Sohail; David L Hayes; Paul A Friedman; Walter R Wilson; James M Steckelberg; Larry M Baddour
Journal:  Pacing Clin Electrophysiol       Date:  2009-09-30       Impact factor: 1.976

View more
  1 in total

1.  Acute Psoriatic Exacerbation Secondary to Infected Pacemaker With Staphylococcus aureus and Candida lusitaniae?

Authors:  Ashish Lalani; Caleb Conrad; Shahman Shahab
Journal:  Cureus       Date:  2022-05-17
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.